Yayın:
Anti-diabetic Properties of Calcium Channel Blockers: Inhibition Effects on Aldose Reductase Enzyme Activity

Sadeleştirilmiş öğe sayfası
dc.contributor.authorBEYDEMİR, ŞÜKRÜ
dc.contributor.authorYeliz Demir
dc.contributor.authorŞükrü Beydemir
dc.contributor.orcid0000-0002-2932-2789
dc.contributor.orcid0000-0003-3216-1098
dc.contributor.orcid0000-0003-3667-6902
dc.date.accessioned2025-11-13T09:06:59Z
dc.date.issued2019-04-13
dc.identifier.doihttps://doi.org/10.1007/s12010-019-03009-x
dc.identifier.endpage329
dc.identifier.issn0273-2289
dc.identifier.issue1
dc.identifier.openalexW2940071317
dc.identifier.startpage318
dc.identifier.urihttps://hdl.handle.net/11421/494
dc.identifier.urihttps://doi.org/10.1007/s12010-019-03009-x
dc.identifier.volume189
dc.language.isoen
dc.relation.ispartofApplied Biochemistry and Biotechnology
dc.rightsrestrictedAccess
dc.subjectNitrendipine
dc.subjectIsradipine
dc.subjectChemistry
dc.subjectAldose reductase
dc.subjectCalcium channel
dc.subjectPharmacology
dc.subjectNifedipine
dc.subjectVerapamil
dc.subjectNon-competitive inhibition
dc.subjectSorbitol
dc.subjectAldose reductase inhibitor
dc.subjectCinnarizine
dc.subjectFelodipine
dc.subjectCalcium
dc.subjectDihydropyridine
dc.subjectEnzyme inhibitor
dc.subjectPolyol pathway
dc.subjectIC50
dc.subjectBiochemistry
dc.subjectEnzyme
dc.subjectEndocrinology
dc.subjectMedicine
dc.subjectIn vitro
dc.subjectChromatography
dc.subject.sdg3
dc.titleAnti-diabetic Properties of Calcium Channel Blockers: Inhibition Effects on Aldose Reductase Enzyme Activity
dc.typeArticle
dspace.entity.typePublication
local.authorid.openalexA5081967794

Dosyalar

Koleksiyonlar

Publications